BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 6459336)

  • 1. How effective is surgical adrenalectomy in lowering steroid hormone concentrations?
    Worgul TJ; Santen RJ; Samojlik E; Wells SA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):22-6. PubMed ID: 6459336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
    Samojlik E; Veldhuis JD; Wells SA; Santen RJ
    J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
    Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
    J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
    Samojlik E; Santen RJ
    J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
    Abraham GE; Maroulis GB
    Obstet Gynecol; 1975 Mar; 45(3):271-4. PubMed ID: 163457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
    Samojlik E; Santen RJ; Kirschner MA; Ertel NH
    Cancer Res; 1982 Aug; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical adrenalectomy and plasma steroids in advanced breast carcinoma.
    Newsome HH; Brown PW; Terz JJ; Lawrence W
    Surgery; 1978 Jan; 83(1):83-9. PubMed ID: 619476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma estrone-sulfate: assessment of reduced estrogen production during treatment of metastatic breast carcinoma.
    Samojlik E; Santen RJ; Worgul TJ
    Steroids; 1982 May; 39(5):497-507. PubMed ID: 6293125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
    Geisler J; Haynes B; Anker G; Helle H; Ekse D; Dowsett M; Lønning PE
    J Steroid Biochem Mol Biol; 2005 Sep; 96(5):415-22. PubMed ID: 16168635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum estrogens and androgens in women with endometrial carcinoma.
    Pettersson B; Bergström R; Johansson ED
    Gynecol Oncol; 1986 Oct; 25(2):223-33. PubMed ID: 2944804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism.
    Rosenthal KL; Peterson ME
    J Am Vet Med Assoc; 1996 Sep; 209(6):1097-102. PubMed ID: 8800255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen and estrogen dynamics in pre- and postmenopausal women: a comparison between smokers and nonsmokers.
    Longcope C; Johnston CC
    J Clin Endocrinol Metab; 1988 Aug; 67(2):379-83. PubMed ID: 3392163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of unconjugated androgens and estrogens by the normal and abnormal human testis before and after human chorionic gonadotropin.
    Weinstein RL; Kelch RP; Jenner MR; Kaplan SL; Grumbach MM
    J Clin Invest; 1974 Jan; 53(1):1-6. PubMed ID: 4271572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hormonal activity of the postmenopausal ovary.
    Vermeulen A
    J Clin Endocrinol Metab; 1976 Feb; 42(2):247-53. PubMed ID: 177438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.